NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022

Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age

(2020) Colin Flannelly et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement

(2019) Jeannine S. McCune et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases

(2019) Dimana Dimitrova et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Pentotstatin/TBI Conditioning Is Well-Tolerated and Permits Engraftment of a Second Allogeneic Stem Cell Transplant Following Primary or Secondary Rejection of an Allogeneic Hematopoietic Stem Graft

(2019) Ani Gvajaia et al.   BLOOD

Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors Before and After Allogeneic transplantation

(2018) Awais Ijaz et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies

(2018) Patrice Chevallier et al.   Oncotarget

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival

(2018) Amin Alousi et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation

(2016) Stephanie J. Lee et al.   JAMA Oncology

Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation

(2015) Navneet S. Majhail et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Conditioning Chemotherapy Dose Adjustment in Obese Patients: A Review and Position Statement by the American Society for Blood and Marrow Transplantation Practice Guideline Committee

(2014) Joseph Bubalo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation

(2014) Mohamed L. Sorror et al.   JOURNAL OF CLINICAL ONCOLOGY

How I assess comorbidities before hematopoietic cell transplantation

(2013) M. L. Sorror   BLOOD

Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes

(2012) C. G. Brunstein et al.   BLOOD

A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation

(2012) J. Pidala et al.   HAEMATOLOGICA

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

(2012) Claudio Anasetti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Defining the Intensity of Conditioning Regimens: Working Definitions

(2009) Andrea Bacigalupo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION